Conference Coverage

HCQ eye toxicity needs experience to assess

Publish date: July 5, 2016

 

AT THE EULAR 2016 CONGRESS

References

The study was supported by noncommercial grants. Dr. Shah had no conflicts of interest to disclose.

Pages

Recommended Reading

More connective tissue disease–associated PAH seen in older patients
MDedge Rheumatology
Stevens-Johnson syndrome, TEN not as rare as thought
MDedge Rheumatology
Lupus may confer higher risk for cervical cancer
MDedge Rheumatology
Giant cell arteritis survival doubled in the past 2 decades
MDedge Rheumatology
VIDEO: FDG-PET/CT useful for fever, inflammation of unknown origin
MDedge Rheumatology
European initiative unveils pediatric care recommendations
MDedge Rheumatology
Updated Behçet’s disease recommendations expand biologic treatment
MDedge Rheumatology
European ANCA-associated vasculitis guidance gets first makeover since 2009
MDedge Rheumatology
Actemra may reduce scleroderma skin thickening
MDedge Rheumatology
VIDEO: TNF inhibitors improved refractory skin disease in juvenile dermatomyositis
MDedge Rheumatology